BRIEF-Orexigen Therapeutics announces spanish launch of Mysimba

* Orexigen Therapeutics announces spanish launch of Mysimba (naltrexone hcl / bupropion hcl prolonged release) in partnership with laboratorios Farmaceuticos Rovi, S.A.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.